RILONACEPT vs RISANKIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RILONACEPT vs RISANKIZUMAB: Safety Overview
| Metric | RILONACEPT | RISANKIZUMAB |
|---|---|---|
| Total FAERS Reports | 843 | 2,642 |
| Deaths Reported | 14 | 41 |
| Death Rate | 1.7% | 1.6% |
| Hospitalizations | 65 | 439 |
| Average Patient Age | 51.9 yrs | 52.1 yrs |
| % Female Patients | 68.2% | 51.3% |
| Manufacturer | Kiniksa Pharmaceuticals (UK), Ltd. | AbbVie Inc. |
| Route | SUBCUTANEOUS | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |